Mass General Brigham, Inc Portfolio Holdings
Mass General Brigham, Inc
- $20.5 Billion
- Q2 2024
Mass General Brigham, Inc has filed its 13F form on July 31, 2024 for Q2 2024 where it was disclosed a total value porftolio of $20.5 Billion distributed in 52 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Revolution Medicines, Inc. with a value of $13.1B, Pliant Therapeutics, Inc. with a value of $3.1B, Tango Therapeutics, Inc. with a value of $3.04B, and Fulcrum Therapeutics, Inc. with a value of $1.27B.
Examining the 13F form we can see an decrease of $36.6B in the current position value, from $57.1B to 20.5B.
Below you can find more details about Mass General Brigham, Inc portfolio as well as his latest detailed transactions.